Hormone trial for disease prevention stopped earlyBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7355.61 (Published 13 July 2002) Cite this as: BMJ 2002;325:61
- Janice Hopkins Tanne
- New York
A US randomised, placebo controlled, double blind trial to evaluate oestrogen and progestogen in postmenopausal women was stopped early by the Women's Health Initiative because health risks exceeded health benefits by a small margin.
It is the first trial to examine whether continuous oestrogen plus progestogen has a favourable or unfavourable effect on coronary heart disease and overall risks and benefits in healthy women.
JAMA has already posted the article on its website (http://www.jama.com/issues/v288/n3/abs/joc21036.html). The article will then be …